Matches in Nanopublications for { ?s ?p "[The early acquisition of TP53 mutations in the founding HSPC clone probably contributes to the frequent cytogenetic abnormalities and poor responses to chemotherapy that are typical of patients with t-AML/t-MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[The early acquisition of TP53 mutations in the founding HSPC clone probably contributes to the frequent cytogenetic abnormalities and poor responses to chemotherapy that are typical of patients with t-AML/t-MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The early acquisition of TP53 mutations in the founding HSPC clone probably contributes to the frequent cytogenetic abnormalities and poor responses to chemotherapy that are typical of patients with t-AML/t-MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1246153.RAROhLoM3z1-sD7b0BZzrCCi14_wuQfdTsN6FfnLt-MTw130_assertion description "[The early acquisition of TP53 mutations in the founding HSPC clone probably contributes to the frequent cytogenetic abnormalities and poor responses to chemotherapy that are typical of patients with t-AML/t-MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246153.RAROhLoM3z1-sD7b0BZzrCCi14_wuQfdTsN6FfnLt-MTw130_provenance.
- NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_assertion description "[The early acquisition of TP53 mutations in the founding HSPC clone probably contributes to the frequent cytogenetic abnormalities and poor responses to chemotherapy that are typical of patients with t-AML/t-MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_provenance.